Luspatercept Passes Phase 3 Clinical Trial for Rare Blood Disease

July 3, 2018  Source: FierceBiotech 201

A type of blood cancer named myelodysplastic syndromes occurs in people where the blood-forming cells in the bone marrow become abnormal, leading to the depletion of one of more types of blood cells.

Acceleron Pharma and its partner Celgene have revealed that luspatercept hit its primary and secondary endpoints in phase 3 clinical trial of patients affected with chronic anemia associated with a rare blood disease. The need for red blood transfusions is decreased by luspatercept for at least 8-12 consecutive weeks in patients affected with chronic anemia and myelodysplastic syndromes (MDS), where erythropoietin-stimulating agent (ESA) drugs do not work. Luspatercept increases red blood cell production by targeting the transforming growth factor-beta (TGF-beta) proteins, which helps in red cell differentiation and maturation.

Jay Backstrom, M.D., Chief Medical Officer from Celgene said, “This result from the phase III MEDALIST trial demonstrates the potential clinical benefit of luspatercept as an erythroid maturation agent for the treatment of chronic anemia in patients with low-to-intermediate risk MDS.”

Luspatercept is in a late-stage trial in beta-thalassemia. The companies aims to file the drug for approval in the U.S. and Europe during the initial half of 2019 and proceed for human trials in MDS patients who were not treated with ESA before.

By Ddu
Share: 

your submission has already been received.

OK

Subscribe

Please enter a valid Email address!

Submit

The most relevant industry news & insight will be sent to you every two weeks.


Warning: mysqli_query(): (HY000/1194): Table 'wp_posts' is marked as crashed and should be repaired in /data/www/ddu_2017/webapp/channel_drugdu_com/wp-includes/wp-db.php on line 1896

WordPress database error: [Table 'wp_posts' is marked as crashed and should be repaired]
SELECT SQL_CALC_FOUND_ROWS wp_posts.ID FROM wp_posts LEFT JOIN wp_term_relationships ON (wp_posts.ID = wp_term_relationships.object_id) WHERE 1=1 AND ( wp_term_relationships.term_taxonomy_id IN (1,54) ) AND wp_posts.post_type = 'post' AND (wp_posts.post_status = 'publish') GROUP BY wp_posts.ID ORDER BY wp_posts.post_date DESC LIMIT 0, 10